Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Trattamento manipolativo osteopatico e controllo posturale: approccio di ingegneria dei sistemi

20 ottobre 2026 aggiornato da: Jacek Cholewicki, Michigan State University

The overall goal of this project is to develop sensitive and objective clinical research tools for the assessment of postural control of the trunk. In order to accomplish this goal, we aim to quantify balance performance in an unstable seated task. Specifically, the investigators will quantify balance performance in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in balance performance after a single session of osteopathic manipulative treatment as well as after 4 sessions of osteopathic manipulative treatment and this improvement will be greater than any learning effect.

A secondary objective of this study is to quantify differences in patient-oriented outcome measures (e.g., self-reported pain, disability) in low back pain participants before and after osteopathic manipulative treatment. The investigators hypothesize that there will be a significant improvement in these self-reported outcomes following osteopathic manipulative treatment. The association between improvement in postural control parameters and patient-oriented measures will also be explored.

Panoramica dello studio

Stato

Terminato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

95

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Michigan
      • East Lansing, Michigan, Stati Uniti, 48823
        • MSU Osteopathic Manipulative Medicine
      • Lansing, Michigan, Stati Uniti, 48891
        • MSU Musculoskeletal Rehabilitation
      • Lansing, Michigan, Stati Uniti, 48910
        • Michigan State University Center for Orthopedic Research

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 21 anni a 65 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

All participants must meet all of the inclusion criteria to participate in the study. Below is a list of inclusion criteria for LBP participants:

  • Age 21-65 years
  • Independently ambulatory
  • Able to speak and read English
  • Able to understand study procedures and to comply with them for the entire length of the study.
  • Willing to be randomized to either immediate or delayed treatment group.
  • Musculoskeletal pain - primarily in the low back region
  • Pain rating equal to or greater than 3 out of10 as indicated on the Numeric Rating Scale for Pain
  • Disability equal to or greater than 26% as indicated on the Oswestry Disability Questionnaire

Exclusion Criteria:

All candidates meeting any of the exclusion criteria at baseline will be excluded from study participation. Exclusion criteria will be self-reported. However, during each treatment session, the physicians will be watching for clinical signs and symptoms not consistent with physical findings that are suggestive of the presence of any of the exclusion criteria. In such a case, further treatment will be discontinued and the subject will be excluded.

Below is a list of exclusion criteria:

  • Inability or unwillingness of individual to give written informed consent.
  • Physical therapy or any other form of manual medicine (e.g., Osteopathic Manipulative Medicine, Chiropractic Manipulation, etc.), acupuncture or spinal injections within one month prior to study enrollment
  • Workers' compensation benefits in the past 3 months or ongoing medical legal issues
  • Possibly pregnant
  • Obesity (BMI>32)
  • Currently using electrical implants (e.g., cardiac pacemakers, drug delivery pumps, etc.)

History of:

  • Spinal surgery
  • Spinal fracture
  • Spinal infection (e.g., osteomyelitis)
  • Cancer

Unresolved symptoms from:

  • Head trauma
  • Inner ear infection with associated balance and coordination problems
  • Orthostatic hypotension
  • Uncontrolled hypertension
  • Vestibular disorder (e.g. vertigo)

Current diagnosis of:

  • Significant spinal deformity (e.g., scoliosis > 20 degrees, torticollis)
  • Ankylosing spondylitis
  • Spondylolisthesis grades III or IV
  • Cauda equine syndrome
  • Rheumatoid arthritis
  • Osteoporosis
  • Angina or congestive heart failure symptoms
  • Active bleeding or infection in the back
  • Blindness
  • Seizures
  • Neurologic disease (e.g., Parkinson's disease, multiple sclerosis, cerebral palsy, Alzheimer's disease, amyotrophic lateral sclerosis, stroke or transient ischemic attack in the past year, cervical dystonia)

Conditions recognized by a physician any time during the study:

  • Significant or worsening signs of neurologic deficit
  • Symptoms are not consistent with mechanical findings
  • Other conditions impeding protocol implementation

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Triplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: OMT first, then No intervention

This arm received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week), then received no intervention after for approximately 4 weeks.

Up to 4 sessions of osteopathic manipulative treatment (once per week)

No interventions for approximately 4 weeks

Sperimentale: No intervention, then OMT

This arm received no intervention after for approximately 4 weeks, then received osteopathic manipulative treatment (OMT) for approximately 4 weeks (once per week).

Up to 4 sessions of osteopathic manipulative treatment (once per week)

No interventions for approximately 4 weeks

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postural Control
Lasso di tempo: Baseline, Week 1, Week 4 (crossover), & Week 8

Postural control will be assessed in an unstable seated task, in which subjects will be asked to balance on a specially designed seat that wobbles side to side. Participant will be asked to maintain their upright posture while keeping their eyes open. The root mean square error (difference between the trunk angle from their upright position) is computed then converted to Z-score based the study populations' baseline mean and standard deviation. The score ranged from -1.67 to 2.95. Z-score of 0 indicates study population's average at the baseline. Higher Z-score indicates worse performance.

Baseline, Week 1, Week 4 (crossover), & Week 8
Trunk Muscle Reflex Latency
Lasso di tempo: Baseline, Week 1, Week 4 (crossover), & Week 8

Subjects will be pulling with their trunk on a cable held by an electromagnet. The electromagnet will be suddenly released. Trunk muscle response to sudden load release will be measured on electromyographical recordings.

Baseline, Week 1, Week 4 (crossover), & Week 8

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Patient Reported Outcomes Measurement Information System (PROMIS)
Lasso di tempo: Baseline and Week 4 (crossover point)

Assesses changes in physical function, anxiety, depression, fatigue, sleep, satisfaction with social role, and pain with Patient Reported Outcomes Measurement Information System (PROMIS) 29 questionnaire. Patients rated the statements in each domain from 0-5. Scores are summed for each domain (ranges from 4 to 20), and converted to T-scores using PROMIS conversion table (for details see http://www.healthmeasures.net/promis-scoring-manuals) . T-score of 50 indicates population average with a standard deviation of 10. Higher scores indicate worse outcomes for pain interference, sleep disturbance, fatigue, depression, and anxiety; whereas higher scores indicate better outcomes for physical function and Satisfaction with participation in social roles.

Baseline and Week 4 (crossover point)
Concomitant Medication
Lasso di tempo: Baseline, Week 4 (crossover), Week8

Assesses the use of medication with a questionnaire. Patients were asked to report medications used within the past 7 days.

Baseline, Week 4 (crossover), Week8
Oswestry Disability Index
Lasso di tempo: Baseline, Week 4 (crossover), and Week 8

Assesses changes in functional activities related to low back disability with the Oswestry Disability Index questionnaire. Patients selected statements that best described their condition from 10 domains affecting daily life. Each domain is scored from 0 (no disability) to 5 (highest disability). Scores from each domains are summed then percentages are calculated out of 50. Higher percentage is associated with higher disability.

Baseline, Week 4 (crossover), and Week 8
Fear Avoidance Beliefs Questionnaire
Lasso di tempo: Baseline, Week 4 (crossover), and Week 8

The Fear Avoidance Beliefs questionnaire (FABQ) assesses effects of fear-avoidance beliefs about physical activity and work. Patients rated statements on a scale from 0 (completely disagree) to 6 (completely agree). Scores are then summed for each category: "Physical activity" (total of 4 statements, ranges from 0 to 24), and "Work" (total of 7 statements ranges from 0 to 42). Higher scores indicate stronger fear-avoidance belief (i.e. worse outcome).

Baseline, Week 4 (crossover), and Week 8

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Jacek Cholewicki, PhD, Michigan State University
  • Investigatore principale: Norman P Reeves, PhD, Michigan State University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

5 giugno 2015

Completamento primario (Effettivo)

31 agosto 2018

Completamento dello studio (Effettivo)

31 agosto 2018

Date di iscrizione allo studio

Primo inviato

19 settembre 2014

Primo inviato che soddisfa i criteri di controllo qualità

9 ottobre 2014

Primo Inserito (Stimato)

10 ottobre 2014

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

20 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • NCCAM U19 AT006057 Project 1
  • 5U19AT006057-02 (Sovvenzione/contratto NIH degli Stati Uniti)

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .